NF2 and central nervous system neoplasm: Meningiomas have received much less attention than other CNS tumors due to their relative benign nature, despite being the most frequent intracranial tumors [4]; however, nearly 20% of meningiomas recur, without any clear molecular fingerprint for transformation, besides the common chromosome 22q loss, leading to NF2 inactivation [27].